By Abigail Townsend
Date: Monday 22 Sep 2025
(Sharecast News) - Pfizer Inc has agreed to buy biotech Metsera in multi-billion dollar deal, the US drugs giant confirmed on Monday, giving it a foothold in the booming weight-loss sector and sending shares in the start-up soaring.
Patent Woes Threaten Drug Firms | 07-Mar-2011 | New York Times |
Stocks push higher on deals and strong earnings | 09-Feb-2011 | USA Today |
Dow soars to close above 12,000 | 02-Feb-2011 | Wall Street Journal |
Pfizer To Close UK Plant And Axe 2,400 Jobs | 01-Feb-2011 | Sky News |
Despite good earnings reports, stocks tumble | 21-Oct-2009 | Wall Street Journal |
Currency | US Dollars |
Share Price | $ 24.21 |
Change Today | $ 0.17 |
% Change | 0.69 % |
52 Week High | $30.19 |
52 Week Low | $21.59 |
Volume | 19,894,462 |
Shares Issued | 5,667m |
Market Cap | $137,170m |
Beta | 0.43 |
RiskGrade | 102 |
Strong Buy | 4 |
Buy | 5 |
Neutral | 15 |
Sell | 0 |
Strong Sell | 1 |
Total | 25 |
Time | Volume / Share Price |
13:05 | 100 @ $24.21 |
13:05 | 100 @ $24.21 |
13:05 | 100 @ $24.21 |
13:05 | 100 @ $24.21 |
13:05 | 100 @ $24.21 |
You are here: research